← Product Code [KNT](/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KNT) · K970849 # ENTERAL NUTRITION 1000 ML/500ML (K970849) _Medical Infusion Technologies, Inc. · KNT · Aug 15, 1997 · Gastroenterology, Urology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KNT/K970849 ## Device Facts - **Applicant:** Medical Infusion Technologies, Inc. - **Product Code:** [KNT](/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KNT.md) - **Decision Date:** Aug 15, 1997 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 876.5980 - **Device Class:** Class 2 - **Review Panel:** Gastroenterology, Urology - **Attributes:** Therapeutic ## Indications for Use This product must be used only under a doctor’s prescription. Its indications for use are various medical situations wherein the patient is nourished by an appropriate formula by means of a tube passed into the stomach from the nasal passage. It is used for patients who for some reason are unwilling or unable to masticate or swallow food. The product is not for intravenous feeding. ## Device Story Enact Enteral Feeding Bag is a gravity-fed system for dispensing liquid nutrients and medication. Used in clinical or home settings under physician prescription. Device consists of a reservoir bag and tubing for delivery of formula into a nasogastric tube. Operates via gravity; no electronic or automated components. Provides a method for enteral nutrition for patients unable to swallow. Healthcare providers or caregivers manage the administration of nutrients through the system. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics Gravity-fed enteral feeding bag and tubing system. Non-electronic, mechanical device. Materials and design identical to predicate device. ## Regulatory Identification A gastrointestinal tube and accessories is a device that consists of flexible or semi-rigid tubing used for instilling fluids into, withdrawing fluids from, splinting, or suppressing bleeding of the alimentary tract. This device may incorporate an integral inflatable balloon for retention or hemostasis. This generic type of device includes the hemostatic bag, irrigation and aspiration catheter (gastric, colonic, etc.), rectal catheter, sterile infant gavage set, gastrointestinal string and tubes to locate internal bleeding, double lumen tube for intestinal decompression or intubation, feeding tube, gastroenterostomy tube, Levine tube, nasogastric tube, single lumen tube with mercury weight balloon for intestinal intubation or decompression, and gastro-urological irrigation tray (for gastrological use). ## Special Controls *Classification.* (1) Class II (special controls). The barium enema retention catheter and tip with or without a bag that is a gastrointestinal tube and accessory or a gastronomy tube holder accessory is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I (general controls) for the dissolvable nasogastric feed tube guide for the nasogastric tube. The class I device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 876.9. ## Predicate Devices - RPI Enteral Feeding Bag ([K902641](/device/K902641.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} K970849 Medical Infusion Technologies, Inc 6576 East Quaker Street Orchard Park, NY 14127-259 Fax: 716-667-007 Phone: 716-667-006 # Premarket Notification [510(k)] Summary as required by section 807.92(c) Preparation Date: *March 4, 1997* Per requirements of this section, the letter head contains address, phone, and fax numbers of the submitter, Mr John McNeirney, Vice President. Trade name - “Enteral Nutrition” Common name - is Enteral Feeding Bag and accessories Classification name - Gastrointestinal tube and accessories (per CFR 876.5980(a)) The Enteral Nutrition device is equivalent to the RPI Enteral Feeding Bag, manufactured by Ridge Products, Inc., carrying 510(k) number K902641. The device is a common enteral feeding bag. The device will be used for dispensing liquid nutrients and medication under a doctors prescription. The device will be identical to units on the market with the exception of our private label and per HHS Publication FDA 95-4158 “Premarket Notification 510(k), Regulatory Requirements for Medical Devices”, page 3-7 “Clinical data is not needed for most devices cleared by the 510(k) process.” {1} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 AUG 15 1997 Mr. John McNeirney Vice President Medical Infusion Technology, Inc. 6576 East Quaker Street Orchard Park, New York 14127-2593 Re: K970849 Enact™ Enteral Feeding Bag Dated: June 13, 1997 Received: June 17, 1997 Regulatory Class: II 21 CFR §876.5980/Product Code: 78 KNT Dear Mr. McNeirney: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Lillian Yin, Ph.D. Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2} “Indication For Use” 510(k) Number: K970849 This product must be used only under a doctor’s prescription. Its indications for use are various medical situations wherein the patient is nourished by an appropriate formula by means of a tube passed into the stomach from the nasal passage. It is used for patients who for some reason are unwilling or unable to masticate or swallow food. The product is not for intravenous feeding. Robert R. Natting (Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological Devices 510(k) Number K970849 Prescription Use ☑ (Per 21 CFR 801.109) Over-the-Counter Use --- **Source:** [https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KNT/K970849](https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KNT/K970849) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com